Severe acute respiratory syndrome coronavirus 2 infections can cause coronavirus disease
2019 (COVID-19), which manifests with a range of severities from mild illness to life-…

Since the early days marking the first use of nanomedicine in the early 80s, there has been
a meaningful change in the scientific field involving the Fabrication, characterization, and …

A damaging inflammatory response is implicated in the pathogenesis of severe coronavirus
disease 2019 (COVID-19), but mechanisms contributing to this response are unclear. In two …

COVID-19 is associated with a wide range of clinical manifestations, including autoimmune
features and autoantibody production. Here we develop three protein arrays to measure IgG …

The stem of the influenza A virus hemagglutinin (HA) is highly conserved and represents an
attractive target for a universal influenza vaccine. The 18 HA subtypes of influenza A are …

The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
caused a public health crisis that is exacerbated by our poor understanding of correlates of …

Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that have
mutations associated with increased transmission and antibody escape have arisen over the …

A central feature of the SARS-CoV-2 pandemic is that some individuals become severely ill
or die, whereas others have only a mild disease course or are asymptomatic. Here, we report …

The ongoing SARS-CoV-2 pandemic has led to the focused application of resources and
scientific expertise toward the goal of developing investigational vaccines to prevent COVID-19…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific CD4 + T cells are
likely important in immunity against coronavirus 2019 (COVID-19), but our understanding of …